Obagi Medical Products, Inc. (NASDAQ:OMPI)

CAPS Rating: 3 out of 5

A pharmaceutical company focused on the aesthetic and skin health markets. The Company develops and commercializes prescription-based, topical skin health systems.

Results 1 - 20 of 29 : 1 2 Next »

Recs

0
Member Avatar pro505050 (52.06) Submitted: 4/11/2013 6:20:23 PM : Outperform Start Price: $23.95 OMPI Score: -19.80

Valeant: The Sole Suitor for Obagi - Analyst Blog
2:43p ET April 9, 2013 (Zacks.com) Valeant Pharmaceuticals’ (VRX) proposed acquisition of Obagi Medical Products, Inc. (OMPI) received a boost with Merz Pharma Group opting out of the race to purchase Obagi. Merz’s decision ended the bidding war between Valeant and itself.

Merz Pharma’s decision

Recs

0
Member Avatar technicalalerts (< 20) Submitted: 9/13/2011 1:04:34 AM : Outperform Start Price: $9.85 OMPI Score: +80.87

watchlist

Recs

0
Member Avatar Survivn2 (31.05) Submitted: 8/12/2009 3:49:57 AM : Outperform Start Price: $8.64 OMPI Score: +85.49

going with motley fool 5star on this one...schwab rates "c"

Recs

0
Member Avatar SIRGAMBY (28.44) Submitted: 2/17/2009 1:10:47 PM : Outperform Start Price: $6.30 OMPI Score: +136.84

After a check-up from your skin Dr. he/she states you would benefit from this product only avail. in my office. What would you say? Most will buy and try to then return to the same Dr. who compliments your new found youth! Solid balance sheet with exllnt. history to boot up for this econ. downturn. People are vain....stock-up.

Recs

0
Member Avatar osusports10 (70.22) Submitted: 8/2/2008 5:34:17 PM : Outperform Start Price: $9.82 OMPI Score: +88.46

No Debt! Key to growth in a company and undervalued. Will double in the next year after recent drop!

Recs

0
Member Avatar PebbledShore (87.24) Submitted: 7/2/2008 10:22:39 PM : Outperform Start Price: $8.07 OMPI Score: +142.67

What the heck? I need points!

Recs

0
Member Avatar jacobhsieh (59.69) Submitted: 6/9/2008 10:41:34 AM : Outperform Start Price: $8.47 OMPI Score: +141.30

Blah blah blah. You can talk about numbers, and you may be right/wrong about the price

***Bottom line***
My mom uses their stuff like it's crack. Her friends use their products like they're on crack. Every week that goes by, they get more and more of their friends to use the products.

Recs

0
Member Avatar MS732 (< 20) Submitted: 6/9/2008 12:59:03 AM : Outperform Start Price: $9.03 OMPI Score: +121.57

Benefit overweighs the risk. I do not think FDA investigation will start until next year if there is any at all.

Recs

0
Member Avatar scentedflame (87.11) Submitted: 6/6/2008 1:17:07 PM : Outperform Start Price: $8.93 OMPI Score: +125.52

This company used to be in the 20s. It missed earnings a couple times and was oversold like you wouldn't believe (down to 7 dollars). Based on the future prospects of the company and the great valuation, I picked up some shares in real life at 7 dollars. I still think it is undervalued at 9...but it carries some risk.

I like their product strategy (prescription strength skin care). I figure with the conditions for skin in the world only getting worse and the superficiality of people only increasing over time, their products will be in high demand. They are launching a new product in the 4th Q.

Recs

0
Member Avatar mk42wk82 (86.48) Submitted: 6/6/2008 10:20:34 AM : Outperform Start Price: $8.87 OMPI Score: +128.38

Mgmt is strong and charting below S&P

Recs

0
Member Avatar Dart65GTConv (< 20) Submitted: 5/23/2008 8:05:00 AM : Outperform Start Price: $8.05 OMPI Score: +155.88

NO DEPT "Dept free way to be."

Recs

2
Member Avatar TMFOpie (97.23) Submitted: 5/14/2008 11:23:05 AM : Outperform Start Price: $7.82 OMPI Score: +167.20

Whipped up stock, with rich balance sheet and an attractive valuation. I have friends that spend lots of coin on these kinds of products and I don't see that changing. There are some growing pains with any new public company, especially in this market, but they will work through those. The online reviews that I glanced at seem mostly positive although there are a few complaints (a lot around cost). But overall I think it's worth more than $8 per share.

Recs

8
Member Avatar ajblank (66.62) Submitted: 5/14/2008 8:18:51 AM : Outperform Start Price: $7.76 OMPI Score: +169.05

Are you kidding me???? NO DEBT and accumulating cash each quarter, this is the balance sheet that ALL companies which they had. Even with mediocre earnings which they sand bagged for next quarter (huge upside). This is a possible takeover target for a company such as Allergen. Regardless of a possible acquisitions, OMPI WILL BE TRADING AT $16/share mid-June!!

Recs

0
Member Avatar SolidInvestor (< 20) Submitted: 5/13/2008 3:59:14 PM : Outperform Start Price: $7.71 OMPI Score: +170.42

OMPI has missed the last 2 quarters. This is a really humbling experience. Now the market under estimate and OMPI will buckle down to put up a good number. They have great fundamentals, so management has it in them.

Recs

0
Member Avatar dauril (< 20) Submitted: 5/1/2008 9:42:09 AM : Outperform Start Price: $8.28 OMPI Score: +147.03

Vanity among the boomers bodes well for the industry. If $8 isn't the bottom, it is close enough for me.

Recs

1
Member Avatar Alaskatrader42 (30.66) Submitted: 4/28/2008 9:00:19 PM : Outperform Start Price: $7.76 OMPI Score: +167.38

just a really god buy

Recs

0
Member Avatar bedford777 (61.75) Submitted: 4/23/2008 10:45:32 AM : Outperform Start Price: $6.97 OMPI Score: +201.52

This undervalued skin care company with a fairly strong financial statement will appreciate a minimum of 15% each year over the next five years. It is so low that a much larger company could try to purchase this to take advantage of its lineup.

Recs

1
Member Avatar FlipFlops1968 (< 20) Submitted: 4/23/2008 12:01:32 AM : Outperform Start Price: $6.99 OMPI Score: +199.79

I use the products and none compare to the results!

Financials look great, future is bright.

In 4/16/08 @ $7.53 including round trip broker fees.

Recs

1
Member Avatar hanlerris (< 20) Submitted: 4/22/2008 9:36:57 PM : Outperform Start Price: $6.99 OMPI Score: +199.79

I think the stock bottomed out.

Recs

0
Member Avatar ballofwaxx (32.76) Submitted: 4/22/2008 4:55:20 PM : Outperform Start Price: $6.99 OMPI Score: +199.79

intriguing price and fundamentals

Results 1 - 20 of 29 : 1 2 Next »

Featured Broker Partners


Advertisement